Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Core Viewpoint - Guardant Health, Inc. will participate in the 44th Annual J.P. Morgan Healthcare Conference, highlighting its role as a leading precision oncology company focused on cancer care and treatment [1][2]. Company Overview - Guardant Health is dedicated to transforming patient care and accelerating new cancer therapies through advanced blood and tissue tests, real-world data, and AI analytics [3]. - The company aims to improve outcomes across all stages of cancer care, including early screening, monitoring for recurrence, and treatment selection for advanced cancer patients [3]. - Founded in 2012, Guardant Health emphasizes its mission to guard wellness and extend the time individuals can live free from cancer [3].